Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
03/2003
03/20/2003CA2459766A1 Oxazolidinone and/or isoxazoline as antibacterial agents
03/20/2003CA2459560A1 Methods of kidney transplantation utilizing developing nephric tissue
03/20/2003CA2458628A1 Use of substituted aminomethyl chromans in the treatment of movement disorders
03/20/2003CA2457717A1 Use of compounds in a dry powder inhaler
03/19/2003EP1292604A1 2-aminocarbonyl-9h-purine derivatives
03/19/2003EP1292594A1 Quinazoline derivatives for the treatment of tumours
03/19/2003EP1292319A2 Extracts from spermatophyte plants with antitumor activity
03/19/2003EP1292303A1 A stable pharmaceutical formulation comprising torsemide modification ii
03/19/2003EP1292274A2 Method of making enhanced efficacy antiperspirant actives
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404472A Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
03/18/2003US6534534 Administering indazole-3-methyleneoxyalkanoic acid derivative to treat atherosclerosis
03/18/2003US6534070 Composition with azelaic acid
03/18/2003CA2223722C Keratin fibre oxidation dye composition and dye process using the composition
03/13/2003WO2003020762A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003WO2003020748A1 Anti-cancer cyclopenta[g]quinazoline compounds
03/13/2003WO2003020261A1 Pharmaceutical composition comprising lumiracoxib
03/13/2003WO2003020249A1 Plaster for the treatment of dysfunctions and disorders of nails
03/13/2003WO2003020218A2 Salvianolic acid b
03/13/2003WO2003020206A2 Use of atazanavir in hiv therapy
03/13/2003WO2002060379A3 Composition comprising extracts of flos lonicerae, fructus forsythiae and radix scutellariae, uses and preparation thereof
03/13/2003WO2002043762A3 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
03/13/2003US20030049725 Anti-TNF antibodies, compositions, methods and uses
03/13/2003CA2459406A1 Salvianolic acid b
03/13/2003CA2459348A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003CA2458807A1 Use of atazanavir in hiv therapy
03/13/2003CA2458399A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
03/12/2003EP1290136A1 Novel probiotics for pet food applications
03/12/2003EP1289999A1 Antitumoral analogs of et-743
03/12/2003EP1289481A2 Emulsions with naphthalate esters
03/12/2003EP0895478B1 Component b as cicatrizant
03/12/2003CN1402730A Thiazolo (4,5-D) pyrimidine compounds
03/12/2003CN1402702A Beta 2-adrenergic receptor agonists
03/12/2003CN1402629A Pharmaceutical compositions providing enhanced drug concentrations
03/12/2003CN1401334A Compound 'Shuanghuanglian' preparation and preparing process thereof
03/11/2003US6531119 Soap based gelled antiperspirant or deodorant composition comprising as an anti-irritant at least one polyethylene glycol diisostearate which has an average degree of ethoxylation of from 40-100
03/11/2003US6530959 Dyeing composition for keratinous fibres with a direct cationic coloring agent and a surfactant
03/11/2003CA2291743C Leave-on antimicrobial compositions
03/06/2003WO2003018582A1 Novel imidazopyridine compounds with therapeutic effect
03/06/2003WO2003018031A2 Single dose azithromycin for treating respiratory infections
03/06/2003WO2003017931A2 Simmondsin processing methods and products
03/06/2003WO2003017919A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
03/06/2003WO2002100322A3 Cosmetic composition for nails, free of phthalates, camphor and aromatic solvent
03/06/2003WO2002058625A3 Herbal composition for angina pectoris, method to prepare same and uses thereof
03/06/2003US20030045856 Mechanical fastening system having orthogonally oriented engagement members
03/06/2003US20030045721 Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
03/06/2003US20030045578 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
03/06/2003US20030045518 Certain bis(thio-hydrazide amide) compounds significantly enhance the anticancer activity of taxol.
03/06/2003US20030045501 Use of atazanavir in HIV therapy
03/06/2003US20030045479 Novel N-formyl hydroxylamine compounds, compositions and methods of use
03/06/2003US20030044477 Simmondsin processing methods and products
03/06/2003US20030044446 A multilayered film comprising a first, water-soluble adhesive layer to be placed in contact with a mucosal surface and a second, water-erodible non-adhesive backing layer that controls residence time; drug delivery from mouth
03/06/2003CA2458135A1 Single dose azithromycin for treating respiratory infections
03/06/2003CA2456350A1 Novel imidazopyridine compounds with therapeutic effect
03/06/2003CA2451740A1 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof
03/05/2003EP1287820A1 Aerosol compositions
03/05/2003EP1287004A1 Synthetic process for the manufacture of an ecteinascidin compound
03/05/2003EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
03/05/2003EP1286681A1 Irradiation of ispaghula
03/05/2003EP1286672A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
03/05/2003EP1286644A1 Ceramic material for dental applications and a method for the production thereof
03/05/2003EP1131059B1 Dry powder for inhalation
03/05/2003EP0991641B1 Crystalline form of omeprazole sodium salt
03/05/2003EP0969819B1 New crystalline form of omeprazole
03/05/2003CN1399950A Monoglyceryl or polyglyceryl fatty alcohol, special polyol and oxidizing dye composite for keratin fiber
03/05/2003CN1102382C Preparation and methods for the treatment of T cell mediated diseases
03/05/2003CN1102376C Improved anti dandruff shampoo
03/04/2003US6528486 Peptide agonists of GLP-1 activity
03/04/2003US6528093 Sustained-release preparation
02/2003
02/27/2003WO2003016306A1 Hiv inhibiting pyrimidines derivatives
02/27/2003WO2003016302A1 Diamine derivatives
02/27/2003WO2003015812A2 Beta-amyloid-analogue-t-cell epitop vaccine
02/27/2003WO2003015770A1 Novel combination
02/27/2003WO2003015748A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
02/27/2003WO2003000204A3 Multivalent mycoplasma bacterin
02/27/2003WO2002060391A3 Pharmaceutical composition for the prevention and treatment of scar tissue
02/27/2003US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer
02/27/2003US20030039698 Sustained-release preparation
02/27/2003CA2459692A1 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
02/27/2003CA2457041A1 Novel combination
02/27/2003CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors
02/26/2003EP1285664A2 Methods of increasing lean tissue mass using OB protein compositions
02/26/2003EP1285652A1 Novel fatty acid analogues for the treatment of hypertension
02/26/2003EP1284601A2 Allantoin-containing skin cream
02/26/2003EP1284596A2 APPARATUS AND PROCESS FOR i IN SITU /i MANUFACTURE OF ESSENCE FROM LIVING, UNCUT PLANTS
02/26/2003CN1399639A New oxabispidine compound useful in treatment of cardiac arrhythmias
02/26/2003CN1398582A Local acne treating device
02/25/2003US6525060 Triazolo(4,5-d)pyrimidine compounds
02/25/2003US6525048 Aminomethylphenoxymethyl/benzisoxazole substituted azabicyclic compounds; depression, generalized anxiety disorder, obesity, migraine; 2-(5-Fluoro-benzo(d)isoxazol-3-y)-7-(3-morpholin-4-ylmethylphenoxymethyl) -octahydro-pyrido(1,2-a)pyrazine;
02/22/2003CA2355573A1 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts
02/20/2003WO2003013562A1 Artichoke leaf extracts
02/20/2003WO2003013428A2 Nutritional supplements and methods of using same
02/20/2003WO2002065979A3 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
02/20/2003WO2002064126A3 Method of treating of demyelinating diseases or conditions
02/20/2003US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
02/20/2003US20030036504 Modululation of both fasting and postprandial lipid levels.
02/20/2003US20030036082 Screening methods
02/20/2003US20030035853 Antiinflammatory agents, analgesics; fatty acid mixture and plant extracts
1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 295